|
BAC
|
Financial Services |
BMO Capital |
Downgrade
|
Outperform
→
Market Perform
|
—
|
$386.6B
|
$35.64
|
-1.9%
|
-2.1%
|
-0.1%
|
-0.7%
|
+1.0%
|
+0.2%
|
|
NVO
|
Healthcare |
Guggenheim Securities |
Downgrade
|
Buy
→
Neutral
|
—
|
$197.0B
|
$29.18
|
-2.5%
|
-2.1%
|
-0.2%
|
-0.1%
|
-0.2%
|
+1.0%
|
|
NVO
|
Healthcare |
Guggenheim |
Downgrade
|
Buy
→
Neutral
|
—
|
$197.0B
|
$29.18
|
-2.5%
|
-2.1%
|
-0.2%
|
-0.1%
|
-0.2%
|
+1.0%
|
|
INCY
|
Healthcare |
Mizuho |
Downgrade
|
Buy
→
Neutral
|
—
|
$19.2B
|
$85.97
|
-11.4%
|
-9.4%
|
-0.7%
|
-0.3%
|
-0.8%
|
+1.9%
|
|
IVZ
|
Financial Services |
RBC Capital |
Downgrade
|
Outperform
→
Sector Perform
|
—
|
$12.0B
|
$17.99
|
-2.5%
|
-1.8%
|
+0.7%
|
-0.2%
|
+0.3%
|
+1.1%
|
|
CHH
|
Consumer Cyclical |
Baird |
Downgrade
|
Outperform
→
Neutral
|
—
|
$4.9B
|
$104.35
|
-1.9%
|
-1.7%
|
-0.4%
|
-1.0%
|
-0.1%
|
-0.2%
|
|
MD
|
Healthcare |
Citigroup |
Downgrade
|
Buy
→
Neutral
|
—
|
$2.0B
|
$27.49
|
-3.5%
|
-1.5%
|
+0.0%
|
-0.9%
|
+1.9%
|
-1.7%
|
|
NEWT
|
Financial Services |
Raymond James |
Downgrade
|
Market Perform
→
Underperform
|
—
|
$330M
|
$22.79
|
-0.7%
|
+0.3%
|
+0.2%
|
-0.3%
|
-3.1%
|
-0.3%
|